|

Prediction of Myocardial Injury After Non-Cardiac Surgery in Urologic Cancer Patients

RECRUITINGSponsored by Korea University Anam Hospital
Actively Recruiting
SponsorKorea University Anam Hospital
Started2026-07-15
Est. completion2028-12-31
Eligibility
Age60 Years+
Healthy vol.Accepted

Summary

This prospective multicenter observational study aims to evaluate the predictive value of artificial intelligence-based analysis of preoperative 12-lead electrocardiography for myocardial injury after non-cardiac surgery (MINS) and major adverse cardiovascular events (MACE) within 30 days after surgery in patients undergoing non-cardiac surgery for urologic cancer.

Eligibility

Age: 60 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥ 60 years
* Patients scheduled for major non-cardiac surgery under general anesthesia due to urologic cancer (e.g., radical prostatectomy, radical nephrectomy, partial nephrectomy)
* Patients who undergo preoperative standard 12-lead electrocardiography
* Patients classified as having intermediate or higher surgical risk
* Patients who can be followed for at least 30 days postoperatively
* Patients who voluntarily provide written informed consent to participate in this study

Exclusion Criteria:

* History of major adverse cardiovascular events (MACE) within 6 months prior to surgery
* Inability to obtain essential clinical information required for study participation and follow-up
* Patients who are not hospitalized after surgery
* Individuals deemed inappropriate for participation in the study by the investigator due to legal or psychiatric reasons

Conditions5

CancerHeart DiseaseMajor Adverse Cardiovascular Events (MACE)Myocardial Injury After Non-Cardiac SurgeryUrologic Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.